<http://webisa.webdatacommons.org/prov/49004834>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/412971216> .
<http://webisa.webdatacommons.org/prov/472740424>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/412971216> .
<http://webisa.webdatacommons.org/412971216>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/412971216>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<phy.so> .
<http://webisa.webdatacommons.org/412971216>	<http://www.w3.org/ns/prov#value>	"Researchers have identified a protein that offers a new focus for developing targeted therapies to tame the severe inflammation associated with multiple sclerosis (MS), colitis and other autoimmune disorders." .